Sacroiliitis as an Initial Manifestation of Acute Myelogenous Leukemia

被引:1
作者
Takumi Hoshino
Takafumi Matsushima
Yasuyuki Saitoh
Arito Yamane
Makiko Takizawa
Hiroyuki Irisawa
Takayuki Saitoh
Hiroshi Handa
Norifumi Tsukamoto
Masamitsu Karasawa
Hirokazu Murakami
Yoshihisa Nojima
机构
[1] Gunma University Graduate School of Medicine,Department of Medicine and Clinical Science
[2] Gunma University,School of Health Sciences Faculty of Medicine
[3] Gunma University Hospital,Division of Blood Transfusion Service
来源
International Journal of Hematology | 2006年 / 84卷
关键词
Sacroiliitis; AML; AS;
D O I
暂无
中图分类号
学科分类号
摘要
Sacroiliitis is the most pathognomonic and earliest manifestation of ankylosing spondylitis.We herein report a 28-year-old female patient who presented with sacroiliitis as an initial manifestation of acute myelogenous leukemia (AML). She had a 3-month history of anemia and walking difficulty. Bone marrow findings revealed an increase of blasts with trilineage dysplasia. Although she was initially diagnosed with myelodysplastic syndrome (MDS), blasts rapidly increased and AML developed 1 month after the diagnosis of MDS with sacroiliitis. Induction chemotherapy failed to induce a complete remission of AML, but it did effectively treat the sacroiliitis. However, the sacroiliitis relapsed when the leukemia cells progressed thereafter. Oral corticosteroids helped ameliorate the sacroiliitis. She underwent bone marrow transplantation (BMT) from an HLA-identical sister during a nonremission period; however, the leukemic cells began to rapidly increase from day 30 after BMT. The close relationship between the occurrence of sacroiliitis and AML suggested that autoimmune sacroiliitis was a paraneoplastic phenomenon of AML in this patient. Although autoimmune disorders develop in a substantial number of MDS patients, they are rarely observed in de novo AML. No previous report has described sacroiliitis as the initial manifestation of de novo AML.
引用
收藏
页码:421 / 424
页数:3
相关论文
共 50 条
  • [31] Nucleophosmin mutations in Chinese adults with acute myelogenous leukemia
    Ruan, Guo-Rui
    Li, Jin-Lan
    Qin, Ya-Zhen
    Li, Ling-Di
    Xie, Min
    Chang, Yan
    Zhang, Yan
    Liu, Yan-Rong
    Jiang, Bin
    Chen, Shan-Shan
    Huang, Xiao-Jun
    [J]. ANNALS OF HEMATOLOGY, 2009, 88 (02) : 159 - 166
  • [32] Central Diabetes Insipidus in the Setting of Acute Myelogenous Leukemia
    Dy, Pearl
    Chua, Patrick
    Kelly, Jennifer
    Liebman, Scott
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2012, 60 (06) : 998 - 1001
  • [33] Acute sacroiliitis as a manifestation of calcium pyrophosphate dihydrate crystal deposition disease - A report of two cases
    Francois, S
    GuaydierSouquieres, G
    Marcelli, C
    [J]. REVUE DU RHUMATISME, 1997, 64 (7-9): : 508 - 512
  • [34] Extramedullary infiltration at diagnosis and prognosis in children with acute myelogenous leukemia
    Kobayashi, Ryoji
    Tawa, Akio
    Hanada, Ryoji
    Horibe, Keizo
    Tsuchida, Masahiro
    Tsukimoto, Ichiro
    [J]. PEDIATRIC BLOOD & CANCER, 2007, 48 (04) : 393 - 398
  • [35] ON THE CELLULAR PHARMACOKINETICS OF 6-THIOGUANINE IN ACUTE MYELOGENOUS LEUKEMIA
    LILIEMARK, J
    PETTERSSON, B
    JARNMARK, M
    PETERSON, C
    [J]. LEUKEMIA & LYMPHOMA, 1991, 4 (04) : 271 - 276
  • [36] FLUDARABINE AND ARABINOSYLCYTOSINE THERAPY OF REFRACTORY AND RELAPSED ACUTE MYELOGENOUS LEUKEMIA
    ESTEY, E
    PLUNKETT, W
    GANDHI, V
    RIOS, MB
    KANTARJIAN, H
    KEATING, MJ
    [J]. LEUKEMIA & LYMPHOMA, 1993, 9 (4-5) : 343 - 350
  • [37] Differentiation therapy in acute myelogenous leukemia (non-APL)
    Waxman, S
    [J]. LEUKEMIA, 2000, 14 (03) : 491 - 496
  • [38] Cytogenetic and hematological spontaneous remission in a case of acute myelogenous leukemia
    Fozza, C
    Bellizzi, S
    Bonfigli, S
    Campus, PM
    Dore, F
    Longinotti, M
    [J]. EUROPEAN JOURNAL OF HAEMATOLOGY, 2004, 73 (03) : 219 - 222
  • [39] Differentiation therapy in acute myelogenous leukemia (non-APL)
    S Waxman
    [J]. Leukemia, 2000, 14 : 491 - 496
  • [40] Sorafenib as treatment for relapsed or refractory pediatric acute myelogenous leukemia
    Watt, Tanya C.
    Cooper, Todd
    [J]. PEDIATRIC BLOOD & CANCER, 2012, 59 (04) : 756 - 757